Email: cspc@cspc.cn
Media
News Center
Oct. 20
2026
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2083 EYE DROPS FOR THE TREATMENT OF DRY EYE DISEASE OFFICIALLY INITIATED IN CHINA
Oct. 15
VOLUNTARY ANNOUNCEMENT - SYS6062 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
VOLUNTARY ANNOUNCEMENT - SYS6088 INJECTION (A TRI-SPECIFIC ANTIBODY) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Sep. 29
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HERPES ZOSTER VACCINE (SYS6052) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
VOLUNTARY ANNOUNCEMENT - PHASE IB CLINICAL TRIAL OF JMT206 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT
Sep. 28
VOLUNTARY ANNOUNCEMENT - SYS6077 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us